Investors flee COVID pill drugmaker on report tying treatment to birth defects

This post was originally published on this site

https://content.fortune.com/wp-content/uploads/2022/04/GettyImages-1235943521.jpg

Shionogi COVID pill: Investors flee drugmaker on news of birth defect risk | Fortune

You need to enable JavaScript to view this site.